Sharyn Baker, PharmD, PhD, receives 2022 Distinguished Scholar Award
Sharyn Baker, PharmD, PhD, Gertrude Parker Heer Chair in Cancer Research, professor and chair of the Division of Pharmaceutics and Pharmacology at The Ohio State University College of Pharmacy, and associate director of shared resources at Ohio State's Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, received the 2022 Distinguished Scholar Award. The award was announced to a surprised Dr. Baker by senior leadership of the Enterprise for Research, Innovation and Knowledge at a recent College of Pharmacy meeting.
Dr. Baker is a pharmacologist and leader in translational cancer therapeutics. She has contributed to the development of safe and effective single-agent and combination drug therapies for adults and children with various forms of cancer. A major portion of her career has focused on the development of effective therapies for acute myeloid leukemia (AML) in pediatric and adult populations. Dr. Baker was among the first to identify a treatment strategy against tyrosine kinase inhibitors resistance due to somatic mutations, which is a key driver of leukemic cell growth in AML. Her research has led to the initiation of several clinical trials in children and adults, which has contributed to the FDA approval of new drugs and drug combinations with improved safety and anti-cancer activity.
Dr. Baker has authored over 200 peer-reviewed articles. According to Google Scholar, she is among the top two most cited scholars for cancer chemotherapy, top three for acute myeloid leukemia and one of two females in the top fifty for clinical pharmacology. She has held editorial board appointments with various journals such as the Journal of Clinical Oncology and mentored over 40 postdoctoral PhD, PharmD and MD researchers.
Dr. Baker has authored over 200 peer-reviewed articles. According to Google Scholar, she is among the top two most cited scholars for cancer chemotherapy, top three for acute myeloid leukemia and one of two females in the top fifty for clinical pharmacology. She has held editorial board appointments with various journals such as the Journal of Clinical Oncology and mentored over 40 postdoctoral PhD, PharmD and MD researchers.
The Distinguished Scholar Award is among the highest annual honors awarded at Ohio State. The university-level award honors six faculty members who demonstrate scholarly activity, conduct research or creative works, represent exceptional achievements in their fields, and garnered distinction for the university.
Award recipients are nominated by their departments and chosen by a committee of senior faculty, including past award recipients. Distinguished Scholars receive an honorarium and a research grant to be used over the next three years.